Get started
ProPhase Labs, Inc.ProPhase Labs, Inc.ProPhase Labs, Inc.

ProPhase Labs, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Options

PRPH chart


Full chart

PRPH upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪12.07 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.5032 USD
Net income (FY)
‪−53.36 M‬ USD
Revenue (FY)
‪6.77 M‬ USD
Shares float
‪36.97 M‬
Beta (1Y)
0.77

Employees


Employees (FY)
96
Change (1Y)
−17 −15.04%
Revenue / Employee (1Y)
‪70.52 K‬ USD
Net income / Employee (1Y)
‪−515.89 K‬ USD

About ProPhase Labs, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Ted William Karkus
Website
prophaselabs.com
Headquarters
Garden City
Founded
1989
FIGI
BBG000F5PGF2
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PRPH news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PRPH.

Frequently Asked Questions


The current price of PRPH is 0.2881 USD — it has increased by 2.75% in the past 24 hours. Watch ProPhase Labs, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ProPhase Labs, Inc. stocks are traded under the ticker PRPH.
PRPH stock has risen by 2.53% compared to the previous week, the month change is a −26.03% fall, over the last year ProPhase Labs, Inc. has showed a −96.14% decrease.
PRPH reached its all-time high on Oct 14, 1997 with the price of 22.5821 USD, and its all-time low was 0.2179 USD and was reached on Feb 3, 2025. View more price dynamics on PRPH chart.
See other stocks reaching their highest and lowest prices.
PRPH stock is 13.42% volatile and has beta coefficient of 0.77. Track ProPhase Labs, Inc. stock price on the chart and check out the list of the most volatile stocks — is ProPhase Labs, Inc. there?
Today ProPhase Labs, Inc. has the market capitalization of ‪12.07 M‬, it has decreased by −1.54% over the last week.
Yes, you can track ProPhase Labs, Inc. financials in yearly and quarterly reports right on TradingView.
ProPhase Labs, Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
PRPH earnings for the last quarter are −1.86 USD per share, whereas the estimation was −0.24 USD resulting in a −675.00% surprise. The estimated earnings for the next quarter are −0.18 USD per share. See more details about ProPhase Labs, Inc. earnings.
ProPhase Labs, Inc. revenue for the last quarter amounts to ‪18.95 M‬ USD, despite the estimated figure of ‪3.77 M‬ USD. In the next quarter, revenue is expected to reach ‪2.45 M‬ USD.
PRPH net income for the last quarter is ‪−6.59 M‬ USD, while the quarter before that showed ‪−6.15 M‬ USD of net income which accounts for −7.05% change. Track more ProPhase Labs, Inc. financial stats to get the full picture.
As of Apr 20, 2025, the company has 96 employees. See our rating of the largest employees — is ProPhase Labs, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ProPhase Labs, Inc. EBITDA is ‪−27.45 M‬ USD, and current EBITDA margin is −472.45%. See more stats in ProPhase Labs, Inc. financial statements.
Like other stocks, PRPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ProPhase Labs, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ProPhase Labs, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ProPhase Labs, Inc. stock shows the sell signal. See more of ProPhase Labs, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.